Bay Street News, May 13th, 2024

Presented data from EVANGELINE study showing 100% disease control rate at 24-weeks Initiated study evaluating (Z)-endoxifen in combination with abemaciclib […]

UK submission for national MAA review follows recently received positive opinion from Committee for Medicinal Products for Human Use (CHMP) […]

MONTREAL and SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) — Coveo Solutions Inc. (“Coveo”) (TSX: CVO), the leading provider of […]

Gopuff, a delivery service that brings thousands of products to your doorstep in minutes, will aid in turning Safety Shot […]

LAS VEGAS, May 13, 2024 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified […]

SAN MATEO, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the leading specialized storage cloud, today announced […]

WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology […]

TAMPA, FL, May 13, 2024 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a […]

BOSTON, May 13, 2024 (GLOBE NEWSWIRE) — The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following […]

First Portable Nuclear Microreactor Company Publicly Listed in the U.S. NANO Nuclear seeking to be a diversified and vertically integrated […]